Biofrontera Inc.(BFRI)

Medical - Pharmaceuticals · Woburn, MA

$0.92+0.03 (+3.65%)

Delayed quote: Oct 6, 2026, 11:38 AM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T15:41:02.837Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:41:02.837Z.

Quote observation: 2026-10-06T15:38:57.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 11,822,608
TTM free cash flow · period ending 2026-06-30: -7,934,000

FMP input reference: b47096c20191003074eea3dc75a1498d2bed5743fa2797f84e024bc92f81a74c

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BFRI Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

BFRI Competitors' Price/FCF Ratio

BFRI

Biofrontera Inc.

Current

Market Cap

$11.82M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHIO

Phio Pharmaceuticals Corp.

vs BFRI

Market Cap

$11.44M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRIX

IRIDEX Corporation

vs BFRI

Market Cap

$12.12M

Price/FCF Ratio

N/A

TTM Avg

9.96

3Y Avg

9.96

5Y Avg

9.96

KPRX

Kiora Pharmaceuticals, Inc.

vs BFRI

Market Cap

$11.30M

Price/FCF Ratio

N/A

TTM Avg

6.98

3Y Avg

6.98

5Y Avg

6.98

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs BFRI

Market Cap

$11.95M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs BFRI

Market Cap

$11.21M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs BFRI

Market Cap

$11.17M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs BFRI

Market Cap

$11.09M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DARE

Dare Bioscience, Inc.

vs BFRI

Market Cap

$12.57M

Price/FCF Ratio

N/A

TTM Avg

4.78

3Y Avg

4.78

5Y Avg

4.78

LSTA

Lisata Therapeutics, Inc.

vs BFRI

Market Cap

$10.93M

Price/FCF Ratio

N/A

TTM Avg

5.33

3Y Avg

5.33

5Y Avg

5.33

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Biofrontera Inc. (BFRI)	$11.82M	N/A	N/A	N/A	N/A
Phio Pharmaceuticals Corp. (PHIO)vs ›	$11.44M	N/A	N/A	N/A	N/A
IRIDEX Corporation (IRIX)vs ›	$12.12M	N/A	9.96	9.96	9.96
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.30M	N/A	6.98	6.98	6.98
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$11.95M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.21M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$11.17M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.09M	N/A	N/A	N/A	N/A
Dare Bioscience, Inc. (DARE)vs ›	$12.57M	N/A	4.78	4.78	4.78
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.93M	N/A	5.33	5.33	5.33

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

BFRI Price/FCF Ratio Metrics

BFRI Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics